Decreased GABA status and reduced GAD65/67 levels are highly relevant to the progression of neuropsychiatric conditions such as schizophrenia, autism, depression and epilepsy, in which suboptimal status of VD was also frequently observed [29,30,31]. This evidence concerns the gene GAD2 and depressive disorder.